Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Quality of Life in Patients Treated with Percutaneous Laser Ablation for Non-Functioning Benign Thyroid Nodules: A Prospective Single-Center Study

  • Oddo, Silvia (Endocrinology Unit, IRCSS San Martino University Hospital-IST) ;
  • Felix, Edineia (Endocrinology Unit, IRCSS San Martino University Hospital-IST) ;
  • Mussap, Michele (Laboratory Medicine Service Unit, IRCSS San Martino University Hospital-IST) ;
  • Giusti, Massimo (Endocrinology Unit, IRCSS San Martino University Hospital-IST)
  • Received : 2016.11.17
  • Accepted : 2017.07.06
  • Published : 2018.02.01
⟨ Previous Next ⟩

Abstract

Objective: While many studies have reported that laser ablation (LA) for benign non-fuctioning thyroid nodules is efficacious in reducing nodular volume and neck symptoms, none have described changes in quality of life (QoL). The purpose of this study was to report post-LA changes in QoL in our cohort of patients. Materials and Methods: Fourteen patients with benign thyroid nodules were involved in a prospective, single-center study and underwent a single session of LA. We evaluated the following: changes in nodule volume, thyroid function, and autoimmunity; adverse events during and after LA; changes in neck discomfort by means of a visual analogic scale (VAS) at one week and 1, 3, 6, and 12 months; and changes in QoL through the 13-scale Thyroid-specific Patient Reported Outcome (ThyPRO) questionnaire at 1, 3, 6, and 12 months. ThyPRO is a validated questionnaire for thyroid diseases, which consists of 13 scales with multiple-choice answers. They investigate several aspects of life that may be impaired by goiter-related compression symptoms, by esthetic alterations and by hypo- or hyperthyroidism. Results: Nodule volume decrease was $-37{\pm}23%$, $-55{\pm}22%$, $-53{\pm}25%$, $-58{\pm}25%$ (p < 0.01 vs. baseline) at the first, third, sixth, and twelfth month, respectively. No hypothyroidism or positivization of autoimmunity was observed. There were no major complications during or after LA. After LA, VAS scores improved significantly from 1 week onwards in 100% of patients, while a significant improvement was seen in the goiter symptoms score after one month, and in the general score and mean values of ThyPRO after six months. Scores on the other ThyPRO scales did not change significantly. Conclusion: Laser ablation is safe and effective in reducing nodule volume and neck symptoms; this is confirmed by improvements in the goiter scale, general score, and mean values of ThyPRO and in the VAS score.

Keywords

References

  1. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26:1-133 https://doi.org/10.1089/thy.2015.0020
  2. Verloop H, Louwerens M, Schoones JW, Kievit J, Smit JW, Dekkers OM. Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies. J Clin Endocrinol Metab 2012;97:2243-2255 https://doi.org/10.1210/jc.2012-1063
  3. Papini E, Pacella CM, Misischi I, Guglielmi R, Bizzarri G2, Dossing H, et al. The advent of ultrasound-guided ablation techniques in nodular thyroid disease: towards a patienttailored approach. Best Pract Res Clin Endocrinol Metab 2014;28:601-618 https://doi.org/10.1016/j.beem.2014.02.004
  4. Fast S, Nielsen VE, Bonnema SJ, Hegedus L. Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy. Eur J Endocrinol 2009;160:517-528 https://doi.org/10.1530/EJE-08-0779
  5. Bandeira-Echtler E, Bergerhoff K, Richter B. Levothyroxine or minimally invasive therapies for benign thyroid nodules. Cochrane Database Syst Rev 2014 Jun 18;(6):CD004098
  6. Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, et al. Ultrasonography diagnosis and imaging-based management of thyroid nodules: Revised Korean society of thyroid radiology consensus statement and recommendations. Korean J Radiol 2016;17:370-395 https://doi.org/10.3348/kjr.2016.17.3.370
  7. Na DG, Lee JH, Jung SL, Kim JH, Sung JY, Shin JH, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol 2012;13:117-125 https://doi.org/10.3348/kjr.2012.13.2.117
  8. Agarwal A, Kocjan G. FNAC thyroid reporting categories: value of using the British Thyroid Association (Thy 1 to Thy 5) thyroid FNAC reporting guidelines. Cytopathology 2009;20:133-134 https://doi.org/10.1111/j.1365-2303.2008.00625.x
  9. Watt T, Hegedüs L, Groenvold M, Bjorner JB, Rasmussen AK, Bonnema SJ, et al. Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur J Endocrinol 2010;162:161-167 https://doi.org/10.1530/EJE-09-0521
  10. Ha EJ, Baek JH, Lee JH. Ultrasonography-based thyroidal and perithyroidal anatomy and its clinical significance. Korean J Radiol 2015;16:749-766 https://doi.org/10.3348/kjr.2015.16.4.749
  11. Baek JH, Lee JH, Valcavi R, Pacella CM, Rhim H, Na DG. Thermal ablation for benign thyroid nodules: radiofrequency and laser. Korean J Radiol 2011;12:525-540 https://doi.org/10.3348/kjr.2011.12.5.525
  12. Pacella CM, Mauri G, Achille G, Barbaro D, Bizzarri G, De Feo P, et al. Outcomes and risk factors for complications of laser ablation for thyroid nodules: a multicenter study on 1531 patients. J Clin Endocrinol Metab 2015;100:3903-3910 https://doi.org/10.1210/jc.2015-1964
  13. Achille G, Zizzi S, Di Stasio E, Grammatica A, Grammatica L. Ultrasound-guided percutaneous laser ablation in treating symptomatic solid benign thyroid nodules: Our experience in 45 patients. Head Neck 2016;38:677-682 https://doi.org/10.1002/hed.23957
  14. Papini E, Rago T, Gambelunghe G, Valcavi R, Bizzarri G, Vitti P, et al. Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules. Results of a three-year multicenter prospective randomized trial. J Clin Endocrinol Metab 2014;99:3653-3659 https://doi.org/10.1210/jc.2014-1826
  15. Dossing H, Bennedbaek FN, Hegedus L. Long-term outcome following interstitial laser photocoagulation of benign cold thyroid nodules. Eur J Endocrinol 2011;165:123-128 https://doi.org/10.1530/EJE-11-0220
  16. Mauri G, Cova L, Monaco CG, Sconfienza LM, Corbetta S, Benedini S, et al. Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int J Hyperthermia 2016 Nov 15 [Epub ahead of print]. https://doi.org/10.1080/02656736.2016.1244707
  17. Cesareo R, Pasqualini V, Simeoni C, Sacchi M, Saralli E, Campagna G, et al. Prospective study of effectiveness of ultrasound-guided radiofrequency ablation versus control group in patients affected by benign thyroid nodules. J Clin Endocrinol Metab 2015;100:460-466 https://doi.org/10.1210/jc.2014-2186
  18. Faggiano A, Ramundo V, Assanti AP, Fonderico F, Macchia PE, Misso C, et al. Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study. J Clin Endocrinol Metab 2012;97:4439-4445 https://doi.org/10.1210/jc.2012-2251
  19. Baek JH, Kim YS, Lee D, Huh JY, Lee JH. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol 2010;194:1137-1142 https://doi.org/10.2214/AJR.09.3372
  20. Jeong WK, Baek JH, Rhim H, Kim YS, Kwak MS, Jeong HJ, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 2008;18:1244-1250 https://doi.org/10.1007/s00330-008-0880-6
  21. Valcavi R, Riganti F, Bertani A, Formisano D, Pacella CM. Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid 2010;20:1253-1261 https://doi.org/10.1089/thy.2010.0189
  22. Che Y, Jin S, Shi C, Wang L, Zhang X, Li Y, et al. Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. AJNR Am J Neuroradiol 2015;36:1321-1325 https://doi.org/10.3174/ajnr.A4276
  23. Bernardi S, Dobrinja C, Fabris B, Bazzocchi G, Sabato N, Ulcigrai V, et al. Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol 2014;2014:934595
  24. Padur AA, Kumar N, Guru A, Badagabettu SN, Shanthakumar SR, Virupakshamurthy MB, et al. Safety and effectiveness of total thyroidectomy and its comparison with subtotal thyroidectomy and other thyroid surgeries: a systematic review. J Thyroid Res 2016;2016:7594615
  25. Wang YC, Zhu JQ, Liu K, Xiong JJ, Xing TF, Han QQ, et al. Surgical outcomes comparison between endoscopic and conventional open thyroidectomy for benign thyroid nodules. J Craniofac Surg 2015;26:e714-e718 https://doi.org/10.1097/SCS.0000000000002223
  26. Crevenna R, Zettinig G, Keilani M, Posch M, Schmidinger M, Pirich C, et al. Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy. Support Care Cancer 2003;11:597-603 https://doi.org/10.1007/s00520-003-0474-4
  27. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short- Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263 https://doi.org/10.1097/00005650-199303000-00006
  28. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233 https://doi.org/10.1097/00005650-199603000-00003
  29. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62 https://doi.org/10.1136/jnnp.23.1.56
  30. Kellner R. A symptom questionnaire. J Clin Psychiatry 1987;48:268-274
  31. Valcavi R, Tsamatropoulos P. Health-related quality of life after percutaneous radiofrequency ablation of cold, solid, benign thyroid nodules: a 2-year follow-up study in 40 patients. Endocr Pract 2015;21:887-896 https://doi.org/10.4158/EP15676.OR
  32. Oddo S, Felix E, Repetto AM, Mussap M, Giusti M. Quality of life in patients treated with radiofrequency ablation for thyroid nodules. Res J Endocrinol Metab 2016 November 1 [Epub]. http://doi.org/10.7243/2053-3640-4-1

Cited by

  1. A Glimpse on Trends and Characteristics of Recent Articles Published in the Korean Journal of Radiology vol.20, pp.12, 2019, https://doi.org/10.3348/kjr.2019.0928
  2. Safety and efficacy of thermal ablation (radiofrequency and laser): should we treat all types of thyroid nodules? vol.36, pp.1, 2018, https://doi.org/10.1080/02656736.2019.1627432
  3. Percutaneous laser ablation for benign and malignant thyroid diseases vol.38, pp.1, 2019, https://doi.org/10.14366/usg.18034
  4. 2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules vol.9, pp.4, 2020, https://doi.org/10.1159/000508484
  5. Thermal Ablation of Benign Thyroid Nodules and Papillary Thyroid Microcarcinoma vol.10, pp.None, 2020, https://doi.org/10.3389/fonc.2020.580431
  6. Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: A systematic review and meta-analysis vol.67, pp.1, 2020, https://doi.org/10.1007/s12020-019-02019-3
  7. Effects of energy-based ablation on thyroid function in treating benign thyroid nodules: a systematic review and meta-analysis vol.37, pp.1, 2018, https://doi.org/10.1080/02656736.2020.1806362
  8. Ultrasound-Guided Thermal Ablation of Thyroid Nodules: Technicalities Progress and Clinical Applications, Especially in Malignant Thyroid Nodules vol.11, pp.None, 2021, https://doi.org/10.3389/fonc.2021.761005
  9. Recurrence and additional treatment of cystic thyroid nodules after ethanol ablation: validation of three proposed criteria vol.40, pp.3, 2018, https://doi.org/10.14366/usg.20039
  10. Assessment of thyroid-specific quality of life in patients with benign symptomatic thyroid nodules treated with radiofrequency or ethanol ablation: a prospective multicenter study vol.41, pp.1, 2022, https://doi.org/10.14366/usg.21003